Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Defra backs tougher rules on neonicotinoids
A growing body of scientific evidence shows neonicotinoids are harmful to bees and other pollinators.
Scientific evidence ‘justifies further restrictions’ - Gove 

Environment secretary Michael Gove has said the UK will support tougher restrictions on the use of neonicotinoids, as a growing body of scientific evidence shows they are harmful to bees and other pollinators.

There is currently an EU-wide ban on the use of three neonicotinoids (clothianidin, imidacloprid and thiamethoxam) on a number of crops that are attractive to bees, such as oilseed rape.

The European Commission has proposed to further restrict these pesticides, so they can only be used on plants in glasshouses. Currently their use is allowed for treating sugar beet and as seed treatment for winter cereals.

Mr Gove said tougher restrictions are justified by scientific evidence on the risks posed to the environment and pollinators. Unless the evidence changes, the government will maintain these restrictions after Brexit.

The move follows advice from the government’s advisory body on pesticides.

“I’ve always been clear I will be led by the science on this matter,” Mr Gove said. “The weight of evidence now shows the risks neonicotinoids pose to our environment, particularly to the bees and other pollinators which play such a key part in our £100 billion food industry, is greater than previously understood.

“I believe this justifies further restrictions on their use. We cannot afford to put our pollinator populations at risk.”

Mr Gove added that he understands the impact that further restrictions will have on farmers and is keen to work with them to investigate alternative approaches.

If the European Commission’s proposal is adopted, the UK would be able to consider emergency authorisations in exceptional circumstances, when the risk to pollinators is sufficiently low.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.